首页> 外文期刊>Journal of general internal medicine >Conflict of Interest Disclosure Policies and Practices in Peer-reviewed Biomedical Journals.
【24h】

Conflict of Interest Disclosure Policies and Practices in Peer-reviewed Biomedical Journals.

机译:同行评审的生物医学期刊中的利益冲突披露政策和实践。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: We undertook this investigation to characterize conflict of interest (COI) policies of biomedical journals with respect to authors, peer-reviewers, and editors, and to ascertain what information about COI disclosures is publicly available. METHODS: We performed a cross-sectional survey of a convenience sample of 135 editors of peer-reviewed biomedical journals that publish original research. We chose an international selection of general and specialty medical journals that publish in English. Selection was based on journal impact factor, and the recommendations of experts in the field. We developed and pilot tested a 3-part web-based survey. The survey included questions about the presence of specific policies for authors, peer-reviewers, and editors, specific restrictions on authors, peer-reviewers, and editors based on COI, and the public availability of these disclosures. Editors were contacted a minimum of 3 times. RESULTS: The response rate for the survey was 91 (67%) of 135, and 85 (93%) of 91 journals reported having an author COI policy. Ten (11%) journals reported that they restrict author submissions based on COI (e.g., drug company authors' papers on their products are not accepted). While 77% report collecting COI information on all author submissions, only 57% publish all author disclosures. A minority of journals report having a specific policy on peer-reviewer 46% (42/91) or editor COI 40% (36/91); among these, 25% and 31% of journals state that they require recusal of peer-reviewers and editors if they report a COI. Only 3% of respondents publish COI disclosures of peer-reviewers, and 12% publish editor COI disclosures, while 11% and 24%, respectively, reported that this information is available upon request. CONCLUSION: Many more journals have a policy regarding COI for authors than they do for peer-reviewers or editors. Even author COI policies are variable, depending on the type of manuscript submitted. The COI information that is collected by journals is often not published; the extent to which such "secret disclosure" may impact the integrity of the journal or the published work is not known.
机译:目的:我们进行了这项调查,以表征生物医学期刊对作者,同行评审和编辑的利益冲突(COI)政策,并确定哪些公开的COI信息是公开的。方法:我们对135位同行评审的发表原始研究的生物医学期刊编辑的便利性样本进行了横断面调查。我们选择了国际上以英文出版的普通和专业医学期刊。选择基于期刊影响因子以及该领域专家的建议。我们开发并试行了一个由三部分组成的基于网络的调查。该调查包括以下问题:针对作者,同行评审和编辑的特定政策的存在;基于COI对作者,同行评审和编辑的特定限制;以及这些公开信息的公开可用性。与编辑进行了至少3次联系。结果:135位受访者中有91位(67%)回应调查,有91位期刊报告有作者COI政策的回应率为85%(93%)。十(11%)种期刊报告称它们基于COI限制作者的投稿(例如,不接受药品公司关于其产品的作者论文)。 77%的人报告收集了所有作者提交的COI信息,而只有57%的人发布了所有作者的公开信息。少数期刊报告对同行评审46%(42/91)或编辑COI 40%(36/91)有特定政策;在这些期刊中,有25%和31%的期刊指出,如果报告了COI,则需要撤回同行审稿人和编辑。只有3%的受访者发布了同行审阅者的COI披露,而12%的发布了编辑者的COI披露,而分别有11%和24%的受访者表示可根据要求提供此信息。结论:与同行评审或编辑相比,有更多的期刊针对作者制定COI政策。甚至作者的COI政策都是可变的,具体取决于提交的手稿类型。期刊收集的COI信息通常不会发布;这种“秘密披露”可能会影响期刊或已发表作品的完整性的程度尚不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号